Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTAR: antidepressants versus running for depression and anxiety
NL-OMON27941Recruiting
- Sponsor
- GGZ inGeest
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of escitalopram and sertraline in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by GGZ inGeest. Started Jun 2012; status: recruiting.
02
Drugs
escitalopramsertraline
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NL-OMON27941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27941.